TARS 内幕交易
TARS 的 SEC Form 4 内幕交易记录
总交易
146
买入
0
买入总额
-
卖出总额
$36.9M
| 信号 | 内幕人 | 职位 | 方向 | 股数 | 价格 | 金额 | 日期 | 信号原因 |
|---|---|---|---|---|---|---|---|---|
| ★★★★★(55) | MOTTIWALA AZIZ | President and CEO | 卖出 | 77,698 | $73.96 | $5.7M | 2026-09-01 | CEO卖出, 董事卖出 |
| ★★★★★(55) | MOTTIWALA AZIZ | President and CEO | 卖出 | 81,332 | $71.85 | $5.8M | 2026-08-25 | CEO卖出, 董事卖出 |
| ★★★★★(53) | AZAMIAN BOBAK R. | President/CEO and Board Chair | 卖出 | 11,964 | $67.00 | $802K | 2026-03-19 | CEO卖出, 董事卖出 |
| ★★★★★(53) | AZAMIAN BOBAK R. | President/CEO and Board Chair | 卖出 | 11,667 | $68.71 | $802K | 2026-03-18 | CEO卖出, 董事卖出 |
| ★★★★★(50) | MOTTIWALA AZIZ | President and CEO | 卖出 | 53,043 | $72.00 | $3.8M | 2026-08-19 | CEO卖出, 董事卖出 |
| ★★★★★(45) | MOTTIWALA AZIZ | President and CEO | 卖出 | 8,000 | $81.80 | $654K | 2026-09-02 | CEO卖出, 董事卖出 |
| ★★★★★(45) | AZAMIAN BOBAK R. | President/CEO and Board Chair | 卖出 | 10,972 | $69.42 | $762K | 2026-03-17 | CEO卖出, 董事卖出 |
| ★★★★★(41) | FARROW JEFFREY S | Chief Financial Officer and Chief Strategy Officer | 卖出 | 14,396 | $60.95 | $877K | 2026-06-16 | CFO卖出, 大额卖出(>$500K) |
| ★★★★★(35) | AZAMIAN BOBAK R. | President/CEO and Board Chair | 卖出 | 7,100 | $90.27 | $641K | 2026-09-04 | CEO卖出, 董事卖出 |
| ★★★★★(35) | AZAMIAN BOBAK R. | President/CEO and Board Chair | 卖出 | 10,000 | $90.56 | $906K | 2026-09-04 | CEO卖出, 董事卖出 |
| ★★★★★(35) | AZAMIAN BOBAK R. | President/CEO and Board Chair | 卖出 | 10,000 | $80.06 | $801K | 2026-09-02 | CEO卖出, 董事卖出 |
| ★★★★★(35) | AZAMIAN BOBAK R. | President/CEO and Board Chair | 卖出 | 10,000 | $61.55 | $616K | 2026-06-17 | CEO卖出, 董事卖出 |
| ★★★★★(35) | AZAMIAN BOBAK R. | President/CEO and Board Chair | 卖出 | 12,500 | $68.78 | $860K | 2026-03-16 | CEO卖出, 董事卖出 |
| ★★★★★(30) | AZAMIAN BOBAK R. | President/CEO and Board Chair | 卖出 | 2,900 | $91.27 | $265K | 2026-09-04 | CEO卖出, 董事卖出 |
| ★★★★★(30) | AZAMIAN BOBAK R. | President/CEO and Board Chair | 卖出 | 5,418 | $61.81 | $335K | 2026-06-17 | CEO卖出, 董事卖出 |
| ★★★★★(30) | AZAMIAN BOBAK R. | President/CEO and Board Chair | 卖出 | 4,582 | $61.24 | $281K | 2026-06-17 | CEO卖出, 董事卖出 |
| ★★★★★(28) | FARROW JEFFREY S | Chief Financial Officer and Chief Strategy Officer | 卖出 | 2,186 | $67.00 | $146K | 2026-03-19 | CFO卖出, 非10b5-1计划卖出 |
| ★★★★★(28) | FARROW JEFFREY S | Chief Financial Officer and Chief Strategy Officer | 卖出 | 2,133 | $68.71 | $147K | 2026-03-18 | CFO卖出, 非10b5-1计划卖出 |
| ★★★★★(28) | FARROW JEFFREY S | Chief Financial Officer and Chief Strategy Officer | 卖出 | 2,111 | $69.42 | $147K | 2026-03-17 | CFO卖出, 非10b5-1计划卖出 |
| ★★★★★(25) | GOODRICH KATHERINE | - | 卖出 | 2,954 | $62.08 | $183K | 2026-06-15 | 董事卖出, 减持超50%持仓 |
| ★★★★★(25) | NEERVANNAN SESHADRI | Chief Operating Officer | 卖出 | 4,589 | $67.00 | $307K | 2026-03-19 | C-suite卖出, 非10b5-1计划卖出 |
| ★★★★★(25) | NEERVANNAN SESHADRI | Chief Operating Officer | 卖出 | 3,610 | $68.71 | $248K | 2026-03-18 | C-suite卖出, 非10b5-1计划卖出 |
| ★★★★★(25) | NEERVANNAN SESHADRI | Chief Operating Officer | 卖出 | 3,125 | $69.42 | $217K | 2026-03-17 | C-suite卖出, 非10b5-1计划卖出 |
| ★★★★★(23) | LIN ELIZABETH YEU | Chief Medical Officer | 卖出 | 5,386 | $90.00 | $485K | 2026-09-04 | 高管卖出, 减持超50%持仓 |
| ★★★★★(23) | LIN ELIZABETH YEU | Chief Medical Officer | 卖出 | 1,590 | $90.00 | $143K | 2026-09-04 | 高管卖出, 减持超50%持仓 |
| ★★★★★(20) | NEERVANNAN SESHADRI | Chief Operating Officer | 卖出 | 8,366 | $76.67 | $641K | 2026-03-04 | C-suite卖出, 大额卖出(>$500K) |
| ★★★★★(18) | WHITFIELD DIANNE C. | Chief Human Resources Officer | 卖出 | 4,174 | $67.00 | $280K | 2026-03-19 | 高管卖出, 非10b5-1计划卖出 |
| ★★★★★(18) | WAHL BRYAN | General Counsel | 卖出 | 4,231 | $67.00 | $283K | 2026-03-19 | 高管卖出, 非10b5-1计划卖出 |
| ★★★★★(18) | MOTTIWALA AZIZ | Chief Commercial Officer | 卖出 | 4,440 | $67.00 | $297K | 2026-03-19 | 高管卖出, 非10b5-1计划卖出 |
| ★★★★★(18) | LIN ELIZABETH YEU | Chief Medical Officer | 卖出 | 390 | $67.00 | $26K | 2026-03-19 | 高管卖出, 非10b5-1计划卖出 |
| ★★★★★(18) | WAHL BRYAN | General Counsel | 卖出 | 4,125 | $68.71 | $283K | 2026-03-18 | 高管卖出, 非10b5-1计划卖出 |
| ★★★★★(18) | LIN ELIZABETH YEU | Chief Medical Officer | 卖出 | 379 | $68.71 | $26K | 2026-03-18 | 高管卖出, 非10b5-1计划卖出 |
| ★★★★★(18) | MOTTIWALA AZIZ | Chief Commercial Officer | 卖出 | 4,330 | $68.71 | $298K | 2026-03-18 | 高管卖出, 非10b5-1计划卖出 |
| ★★★★★(18) | WHITFIELD DIANNE C. | Chief Human Resources Officer | 卖出 | 4,071 | $68.71 | $280K | 2026-03-18 | 高管卖出, 非10b5-1计划卖出 |
| ★★★★★(18) | WAHL BRYAN | General Counsel | 卖出 | 4,084 | $69.42 | $284K | 2026-03-17 | 高管卖出, 非10b5-1计划卖出 |
| ★★★★★(18) | WHITFIELD DIANNE C. | Chief Human Resources Officer | 卖出 | 4,029 | $69.42 | $280K | 2026-03-17 | 高管卖出, 非10b5-1计划卖出 |
| ★★★★★(18) | MOTTIWALA AZIZ | Chief Commercial Officer | 卖出 | 4,286 | $69.42 | $298K | 2026-03-17 | 高管卖出, 非10b5-1计划卖出 |
| ★★★★★(18) | LIN ELIZABETH YEU | Chief Medical Officer | 卖出 | 375 | $69.42 | $26K | 2026-03-17 | 高管卖出, 非10b5-1计划卖出 |
| ★★★★★(16) | LIN ELIZABETH YEU | Chief Medical Officer | 卖出 | 5,387 | $85.00 | $458K | 2026-09-04 | 高管卖出, 减持超20%持仓 |
| ★★★★★(16) | LIN ELIZABETH YEU | Chief Medical Officer | 卖出 | 5,387 | $80.00 | $431K | 2026-09-02 | 高管卖出, 减持超20%持仓 |
| ★★★★★(16) | LIN ELIZABETH YEU | Chief Medical Officer | 卖出 | 1,590 | $80.00 | $127K | 2026-09-02 | 高管卖出, 减持超20%持仓 |
| ★★★★★(15) | LINK WILLIAM J PHD | - | 卖出 | 11,675 | $78.33 | $915K | 2026-09-15 | 董事卖出, 大额卖出(>$500K) |
| ★★★★★(15) | LINK WILLIAM J PHD | - | 卖出 | 12,500 | $78.38 | $980K | 2026-09-15 | 董事卖出, 大额卖出(>$500K) |
| ★★★★★(15) | NEERVANNAN SESHADRI | Chief Operating Officer | 卖出 | 4,564 | $85.00 | $388K | 2026-09-04 | C-suite卖出 |
| ★★★★★(15) | LINK WILLIAM J PHD | - | 卖出 | 10,572 | $61.97 | $655K | 2026-06-15 | 董事卖出, 大额卖出(>$500K) |
| ★★★★★(15) | LINK WILLIAM J PHD | - | 卖出 | 12,500 | $62.12 | $777K | 2026-06-15 | 董事卖出, 大额卖出(>$500K) |
| ★★★★★(15) | NEERVANNAN SESHADRI | Chief Operating Officer | 卖出 | 2,989 | $66.75 | $200K | 2026-03-20 | C-suite卖出 |
| ★★★★★(15) | LINK WILLIAM J PHD | - | 卖出 | 8,378 | $69.03 | $578K | 2026-03-16 | 董事卖出, 大额卖出(>$500K) |
| ★★★★★(13) | LIN ELIZABETH YEU | Chief Medical Officer | 卖出 | 10,773 | $87.50 | $943K | 2026-09-04 | 高管卖出, 大额卖出(>$500K) |
| ★★★★★(10) | LINK WILLIAM J PHD | - | 卖出 | 759 | $79.00 | $60K | 2026-09-15 | 董事卖出 |
| ★★★★★(10) | LINK WILLIAM J PHD | - | 卖出 | 66 | $80.01 | $5K | 2026-09-15 | 董事卖出 |
| ★★★★★(10) | LINK WILLIAM J PHD | - | 卖出 | 1,928 | $62.94 | $121K | 2026-06-15 | 董事卖出 |
| ★★★★★(10) | LINK WILLIAM J PHD | - | 卖出 | 493 | $69.75 | $34K | 2026-03-16 | 董事卖出 |
| ★★★★★(10) | LINK WILLIAM J PHD | - | 卖出 | 3,629 | $68.09 | $247K | 2026-03-16 | 董事卖出 |
| ★★★★★(8) | LIN ELIZABETH YEU | Chief Medical Officer | 卖出 | 3,180 | $87.50 | $278K | 2026-09-04 | 高管卖出 |
| ★★★★★(8) | LIN ELIZABETH YEU | Chief Medical Officer | 卖出 | 4,601 | $73.86 | $340K | 2026-09-01 | 高管卖出 |
| ★★★★★(0) | PYOTT DAVID E I | - | 卖出 | 201 | - | - | 2026-09-15 | |
| ★★★★★(0) | YARNO WENDY L | - | 卖出 | 302 | - | - | 2026-09-15 | |
| ★★★★★(0) | LINK WILLIAM J PHD | - | 卖出 | 201 | - | - | 2026-09-15 | |
| ★★★★★(0) | AZAMIAN BOBAK R. | President/CEO and Board Chair | 卖出 | 0 | $79.31 | - | 2026-09-04 | |
| ★★★★★(0) | LIN ELIZABETH YEU | Chief Medical Officer | 卖出 | 0 | $79.31 | - | 2026-09-04 | |
| ★★★★★(0) | NEERVANNAN SESHADRI | Chief Operating Officer | 卖出 | 0 | $79.31 | - | 2026-09-04 | |
| ★★★★★(0) | AZAMIAN BOBAK R. | President/CEO and Board Chair | 卖出 | 0 | $90.78 | - | 2026-09-02 | |
| ★★★★★(0) | LIN ELIZABETH YEU | Chief Medical Officer | 卖出 | 0 | $90.78 | - | 2026-09-01 | |
| ★★★★★(0) | LINK WILLIAM J PHD | - | 卖出 | 2,417 | - | - | 2026-06-25 | |
| ★★★★★(0) | GOLDBERG ANDREW D. | - | 卖出 | 2,417 | - | - | 2026-06-25 | |
| ★★★★★(0) | YARNO WENDY L | - | 卖出 | 1,209 | - | - | 2026-06-25 | |
| ★★★★★(0) | YARNO WENDY L | - | 卖出 | 3,837 | - | - | 2026-06-25 | |
| ★★★★★(0) | PYOTT DAVID E I | - | 卖出 | 806 | - | - | 2026-06-25 | |
| ★★★★★(0) | GOODRICH KATHERINE | - | 卖出 | 2,417 | - | - | 2026-06-25 | |
| ★★★★★(0) | YARNO WENDY L | - | 卖出 | 2,417 | - | - | 2026-06-25 | |
| ★★★★★(0) | PYOTT DAVID E I | - | 卖出 | 2,417 | - | - | 2026-06-25 | |
| ★★★★★(0) | GOODRICH KATHERINE | - | 卖出 | 3,837 | - | - | 2026-06-25 | |
| ★★★★★(0) | GOLDBERG ANDREW D. | - | 卖出 | 3,837 | - | - | 2026-06-25 | |
| ★★★★★(0) | MORRISON SCOTT W | - | 卖出 | 2,417 | - | - | 2026-06-25 | |
| ★★★★★(0) | LINK WILLIAM J PHD | - | 卖出 | 806 | - | - | 2026-06-25 | |
| ★★★★★(0) | PYOTT DAVID E I | - | 卖出 | 3,837 | - | - | 2026-06-25 | |
| ★★★★★(0) | MORRISON SCOTT W | - | 卖出 | 3,837 | - | - | 2026-06-25 | |
| ★★★★★(0) | CHAUDHURI BHASKAR | - | 卖出 | 2,417 | - | - | 2026-06-25 | |
| ★★★★★(0) | CHAUDHURI BHASKAR | - | 卖出 | 3,837 | - | - | 2026-06-25 | |
| ★★★★★(0) | LINK WILLIAM J PHD | - | 卖出 | 3,837 | - | - | 2026-06-25 | |
| ★★★★★(0) | AZAMIAN BOBAK R. | President/CEO and Board Chair | 卖出 | 0 | - | - | 2026-06-17 | |
| ★★★★★(0) | FARROW JEFFREY S | Chief Financial Officer and Chief Strategy Officer | 卖出 | 27,881 | - | - | 2026-06-15 | |
| ★★★★★(0) | CHAUDHURI BHASKAR | - | 卖出 | 2,954 | - | - | 2026-06-12 | |
| ★★★★★(0) | GOODRICH KATHERINE | - | 卖出 | 2,954 | - | - | 2026-06-12 | |
| ★★★★★(0) | YARNO WENDY L | - | 卖出 | 2,954 | - | - | 2026-06-12 | |
| ★★★★★(0) | LINK WILLIAM J PHD | - | 卖出 | 2,954 | - | - | 2026-06-12 | |
| ★★★★★(0) | GOLDBERG ANDREW D. | - | 卖出 | 2,954 | - | - | 2026-06-12 | |
| ★★★★★(0) | MORRISON SCOTT W | - | 卖出 | 0 | - | - | 2026-06-12 | |
| ★★★★★(0) | MORRISON SCOTT W | - | 卖出 | 2,954 | - | - | 2026-06-12 | |
| ★★★★★(0) | PYOTT DAVID E I | - | 卖出 | 1,383 | - | - | 2026-04-24 | |
| ★★★★★(0) | PYOTT DAVID E I | - | 卖出 | 0 | - | - | 2026-04-24 | |
| ★★★★★(0) | NEERVANNAN SESHADRI | Chief Operating Officer | 卖出 | 0 | - | - | 2026-03-20 | |
| ★★★★★(0) | AZAMIAN BOBAK R. | President/CEO and Board Chair | 卖出 | 0 | - | - | 2026-03-17 | |
| ★★★★★(0) | NEERVANNAN SESHADRI | Chief Operating Officer | 卖出 | 0 | - | - | 2026-03-17 | |
| ★★★★★(0) | LIN ELIZABETH YEU | Chief Medical Officer | 卖出 | 0 | - | - | 2026-03-17 | |
| ★★★★★(0) | AZAMIAN BOBAK R. | President/CEO and Board Chair | 卖出 | 14,878 | - | - | 2026-03-15 | |
| ★★★★★(0) | NEERVANNAN SESHADRI | Chief Operating Officer | 卖出 | 5,097 | - | - | 2026-03-15 | |
| ★★★★★(0) | LIN ELIZABETH YEU | Chief Medical Officer | 卖出 | 0 | - | - | 2026-03-15 | |
| ★★★★★(0) | MOTTIWALA AZIZ | Chief Commercial Officer | 卖出 | 5,524 | - | - | 2026-03-15 | |
| ★★★★★(0) | FARROW JEFFREY S | Chief Financial Officer and Chief Strategy Officer | 卖出 | 13,042 | - | - | 2026-03-15 | |
| ★★★★★(0) | WAHL BRYAN | General Counsel | 卖出 | 24,236 | - | - | 2026-03-15 | |
| ★★★★★(0) | AZAMIAN BOBAK R. | President/CEO and Board Chair | 卖出 | 23,121 | - | - | 2026-03-15 | |
| ★★★★★(0) | WAHL BRYAN | General Counsel | 卖出 | 4,790 | - | - | 2026-03-15 | |
| ★★★★★(0) | WAHL BRYAN | General Counsel | 卖出 | 7,176 | - | - | 2026-03-15 | |
| ★★★★★(0) | NEERVANNAN SESHADRI | Chief Operating Officer | 卖出 | 8,148 | - | - | 2026-03-15 | |
| ★★★★★(0) | FARROW JEFFREY S | Chief Financial Officer and Chief Strategy Officer | 卖出 | 5,022 | - | - | 2026-03-15 | |
| ★★★★★(0) | AZAMIAN BOBAK R. | President/CEO and Board Chair | 卖出 | 66,274 | - | - | 2026-03-15 | |
| ★★★★★(0) | MOTTIWALA AZIZ | Chief Commercial Officer | 卖出 | 8,148 | - | - | 2026-03-15 | |
| ★★★★★(0) | WHITFIELD DIANNE C. | Chief Human Resources Officer | 卖出 | 5,022 | - | - | 2026-03-15 | |
| ★★★★★(0) | NEERVANNAN SESHADRI | Chief Operating Officer | 卖出 | 5,022 | - | - | 2026-03-15 | |
| ★★★★★(0) | AZAMIAN BOBAK R. | President/CEO and Board Chair | 卖出 | 11,300 | - | - | 2026-03-15 | |
| ★★★★★(0) | WHITFIELD DIANNE C. | Chief Human Resources Officer | 卖出 | 4,463 | - | - | 2026-03-15 | |
| ★★★★★(0) | AZAMIAN BOBAK R. | President/CEO and Board Chair | 卖出 | 0 | - | - | 2026-03-15 | |
| ★★★★★(0) | AZAMIAN BOBAK R. | President/CEO and Board Chair | 卖出 | 16,975 | - | - | 2026-03-15 | |
| ★★★★★(0) | WHITFIELD DIANNE C. | Chief Human Resources Officer | 卖出 | 7,176 | - | - | 2026-03-15 | |
| ★★★★★(0) | WAHL BRYAN | General Counsel | 卖出 | 7,248 | - | - | 2026-03-15 | |
| ★★★★★(0) | WHITFIELD DIANNE C. | Chief Human Resources Officer | 卖出 | 23,909 | - | - | 2026-03-15 | |
| ★★★★★(0) | NEERVANNAN SESHADRI | Chief Operating Officer | 卖出 | 0 | - | - | 2026-03-15 | |
| ★★★★★(0) | FARROW JEFFREY S | Chief Financial Officer and Chief Strategy Officer | 卖出 | 8,020 | - | - | 2026-03-15 | |
| ★★★★★(0) | NEERVANNAN SESHADRI | Chief Operating Officer | 卖出 | 8,020 | - | - | 2026-03-15 | |
| ★★★★★(0) | WAHL BRYAN | General Counsel | 卖出 | 5,022 | - | - | 2026-03-15 | |
| ★★★★★(0) | NEERVANNAN SESHADRI | Chief Operating Officer | 卖出 | 26,287 | - | - | 2026-03-15 | |
| ★★★★★(0) | MOTTIWALA AZIZ | Chief Commercial Officer | 卖出 | 4,790 | - | - | 2026-03-15 | |
| ★★★★★(0) | MOTTIWALA AZIZ | Chief Commercial Officer | 卖出 | 26,482 | - | - | 2026-03-15 | |
| ★★★★★(0) | WHITFIELD DIANNE C. | Chief Human Resources Officer | 卖出 | 7,248 | - | - | 2026-03-15 | |
| ★★★★★(0) | MOTTIWALA AZIZ | Chief Commercial Officer | 卖出 | 8,020 | - | - | 2026-03-15 | |
| ★★★★★(0) | LIN ELIZABETH YEU | Chief Medical Officer | 卖出 | 2,511 | - | - | 2026-03-15 | |
| ★★★★★(0) | LIN ELIZABETH YEU | Chief Medical Officer | 卖出 | 17,161 | - | - | 2026-03-05 | |
| ★★★★★(0) | NEERVANNAN SESHADRI | Chief Operating Officer | 卖出 | 17,161 | - | - | 2026-03-05 | |
| ★★★★★(0) | WHITFIELD DIANNE C. | Chief Human Resources Officer | 卖出 | 17,161 | - | - | 2026-03-05 | |
| ★★★★★(0) | NEERVANNAN SESHADRI | Chief Operating Officer | 卖出 | 27,310 | - | - | 2026-03-05 | |
| ★★★★★(0) | WHITFIELD DIANNE C. | Chief Human Resources Officer | 卖出 | 27,310 | - | - | 2026-03-05 | |
| ★★★★★(0) | LIN ELIZABETH YEU | Chief Medical Officer | 卖出 | 27,310 | - | - | 2026-03-05 | |
| ★★★★★(0) | FARROW JEFFREY S | Chief Financial Officer and Chief Strategy Officer | 卖出 | 30,724 | - | - | 2026-03-05 | |
| ★★★★★(0) | AZAMIAN BOBAK R. | President/CEO and Board Chair | 卖出 | 60,776 | - | - | 2026-03-05 | |
| ★★★★★(0) | WAHL BRYAN | General Counsel | 卖出 | 27,310 | - | - | 2026-03-05 | |
| ★★★★★(0) | WAHL BRYAN | General Counsel | 卖出 | 17,161 | - | - | 2026-03-05 | |
| ★★★★★(0) | MOTTIWALA AZIZ | Chief Commercial Officer | 卖出 | 30,724 | - | - | 2026-03-05 | |
| ★★★★★(0) | FARROW JEFFREY S | Chief Financial Officer and Chief Strategy Officer | 卖出 | 19,306 | - | - | 2026-03-05 | |
| ★★★★★(0) | MOTTIWALA AZIZ | Chief Commercial Officer | 卖出 | 19,306 | - | - | 2026-03-05 | |
| ★★★★★(0) | AZAMIAN BOBAK R. | President/CEO and Board Chair | 卖出 | 96,723 | - | - | 2026-03-05 | |
| ★★★★★(0) | NEERVANNAN SESHADRI | Chief Operating Officer | 卖出 | 0 | - | - | 2026-03-04 | |
| ★★★★★(0) | PYOTT DAVID E I | - | 卖出 | 0 | - | - | 2026-02-18 | |
| ★★★★★(0) | PYOTT DAVID E I | - | 卖出 | 3,729 | - | - | 2026-02-18 | |
| ★★★★★(0) | PYOTT DAVID E I | - | 卖出 | 5,893 | - | - | 2026-02-18 |